Trials / Unknown
UnknownNCT04803331
SPIO-enhanced MRI in Oral Cancer for Sentinel Lymph Node Identification
Superparamagnetic Iron Oxide-enhanced Magnetic Resonance Imaging for Sentinel Lymph Node Identification in Oral Cancer: a Feasibility Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Radboud University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To explore the feasibility of sentinel lymph node identification by SPIO injection followed by MRI in head-and-neck cancer patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | SPIO-enhanced MRI | SPIO is peritumorally injected. A T2\*-weighted iron sensitive MRI scan is performed 1 hour later to localize and assess the sentinel lymph nodes. |
Timeline
- Start date
- 2021-07-27
- Primary completion
- 2023-07-01
- Completion
- 2023-07-01
- First posted
- 2021-03-17
- Last updated
- 2022-10-26
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT04803331. Inclusion in this directory is not an endorsement.